drugset / Trial / NCT05047510
GPC3 Targeted Fluorescence Image Guided Surgery of Hepatocellular Carcinoma
NaSingle-groupOpen-labelDiagnostic
Summary
This study is to evaluate whether intraoperative fluorescence imaging targeting GPC3 can aid improve the surgical accuracy of hepatocellular carcinoma. The main purposes of this study include: ① To raise the detection rate of hepatocellular carcinoma intraoperatively using the novel NIR-II fluorescence molecular imaging and the GPC-3 targeted fluorophore. ② To validate the safety and effectiveness of the designed GPC-3 targeted fluorophore for clinical application.
Timeline
- Start
- 2021-09-10
- Primary completion
- 2025-12-31
- Completion
- 2026-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-GPC3-IRDye800CW | Unknown | — | Other |